Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
about
Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 studyA multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trialEthnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects.Population differences in microRNA expression and biological implications.Comparison of the pharmacokinetics, pharmacodynamics and tolerability of tezosentan between caucasian and Japanese subjects.Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsPropofol pharmacokinetics in young healthy Indian subjectsComparative pharmacokinetics of zolpidem tartrate in five ethnic populations of ChinaPrucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.Associations of Genetically Determined Continental Ancestry With CD4+ Count and Plasma HIV-1 RNA Beyond Self-Reported Race and Ethnicity.New developments in the management of relapsed/refractory multiple myeloma - the role of ixazomib.The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (¹⁸F) injection in healthy Japanese adult volunteers.
P2860
Q33425607-8FDAB116-95BC-414D-A342-3306B3FACBA0Q33431621-8EA0A938-7439-4296-AA2E-51D25D0ECF09Q34434351-53A089EE-B585-4CAF-BAC6-0F5B9D65EB4CQ35578546-830C4E4C-1294-4B61-9E8D-8D68148D3D37Q35827520-5D5FF02A-5ADB-4447-A521-FD3E712FC385Q35852614-9D02BA3C-D16C-45FC-B2CC-2B245A60B852Q36018556-0E3DD07D-8958-4CA3-A7D2-A1BFBD962910Q36021049-320C1E8B-6E41-4299-A399-8366E7C30ECDQ36111958-6A3CC910-4E22-40A3-8845-798483E24043Q36431809-CF925D40-8E99-4CD2-83D7-69856E4CD218Q36678096-872779E4-5801-4AF4-9DA0-F3FC27BDA6E3Q38598891-E0C37CC5-B324-4CF9-B227-13CFC5A3C04DQ40868156-B8C771C0-2F50-48ED-BF77-A22D632834A2
P2860
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
@ast
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
@en
type
label
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
@ast
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
@en
prefLabel
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
@ast
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
@en
P356
P1476
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs
@en
P2093
J A Johnson
P356
10.5414/CPP38053
P577
2000-02-01T00:00:00Z